Condition: Colitis, Ulcerative · Sponsor: Pfizer
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in pediatrics participants (≥ 2 years up to \< 12 years of age). Participants who will complete the total 52-week treatment period will have the opportunity to continue in a Long-Term Extension (LTE) Period of up to 4 years (5 years after study enrollment).
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| Health Sciences Centre Winnipeg | Winnipeg, Manitoba, Canada | Not Yet Recruiting |
| Children's Hospital Research Institute of Manitoba | Winnipeg, Manitoba, Canada | Not Yet Recruiting |
| CHU de Québec - Université Laval | Québec, Quebec, Canada | Recruiting |
| Hospices Civils de Lyon - Hôpital Femme Mère Enfant | Bron, Auvergne-Rhône-Alpes, France | Recruiting |
| Hôpital Universitaire Necker Enfants Malades | Paris, France | Not Yet Recruiting |
| Universitätsklinikum Münster - Albert Schweitzer Campus | Münster, North Rhine-Westphalia, Germany | Not Yet Recruiting |
| Universitätsklinikum Leipzig | Leipzig, Saxony, Germany | Not Yet Recruiting |
| Universitaetsklinikum Tuebingen | Tübingen, Germany | Recruiting |
| HELIOS Klinikum Wuppertal | Wuppertal, Germany | Recruiting |
| Sheba Medical Center | Ramat Gan, Central District, Israel | Not Yet Recruiting |
| Yitzhak Shamir Medical Center | Ẕerifin, Central District, Israel | Not Yet Recruiting |
| Shaare Zedek Medical Center | Jerusalem, Jerusalem, Israel | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07470879